Ingersoll Rand (IR)
(Delayed Data from NYSE)
$104.80 USD
+2.19 (2.13%)
Updated Nov 11, 2024 04:00 PM ET
After-Market: $104.80 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$104.80 USD
+2.19 (2.13%)
Updated Nov 11, 2024 04:00 PM ET
After-Market: $104.80 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Zacks News
5 Industrial Product Stocks to Buy on Solid July Data
by Nalak Das
We have narrowed our search to five industrial products stocks. These are: CAT, IR, HUBB, AOS, ETN.
Ingersoll Rand (IR) Closes Roots Deal, Boosts IT&S Offerings
by Zacks Equity Research
Ingersoll Rand (IR) completes acquisition of Roots, expanding its IT&S segment portfolio with incremental low-pressure compression and vacuum technologies.
Are Industrial Products Stocks Lagging Crawford United Corporation (CRAWA) This Year?
by Zacks Equity Research
Here is how Crawford United Corporation (CRAWA) and Ingersoll Rand (IR) have performed compared to their sector so far this year.
Donaldson (DCI) Stock Holds Promise Despite Cost Headwinds
by Zacks Equity Research
Donaldson (DCI) stands to gain from strength in the Industrial Solutions segment and the Univercells acquisition. However, weakness in the Life Sciences segment and cost inflation raise concerns.
These 2 Industrial Products Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
This Top Industrial Products Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
by Zacks Equity Research
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Ingersoll Rand (IR) Q2 Earnings Beat Estimates, '23 View Up
by Zacks Equity Research
Ingersoll Rand's (IR) Q2 results benefit from higher segmental revenues. The company increased its adjusted earnings guidance for 2023.
Compared to Estimates, Ingersoll (IR) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Ingersoll (IR) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ingersoll Rand (IR) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Ingersoll (IR) delivered earnings and revenue surprises of 15.25% and 6.68%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Eaton (ETN) Q2 Earnings & Revenues Beat, 2023 View Raised
by Zacks Equity Research
Eaton's (ETN) second-quarter earnings benefit from the improvement in organic sales. ETN further expands operations during the quarter through strategic acquisitions.
4 Industrial Stocks Poised for a Beat This Earnings Season
by Eshani Haque
Despite demand-softness, improving supply chains and cost-control measures are likely to have aided Q2 earnings of Emerson (EMR), Ingersoll Rand (IR), Illinois Tool (ITW) and Johnson Controls (JCI).
Can Ingersoll Rand (IR) Retain Beat Streak in Q2 Earnings?
by Zacks Equity Research
Ingersoll Rand's (IR) Q2 performance is likely to have benefited from solid underlying demand and higher orders across the Industrial Technologies segment.
Will FoodTech Performance Drive John Bean's (JBT) Q2 Earnings?
by Zacks Equity Research
Improved order levels and a pickup in deliveries due to the easing of supply-chain headwinds, and gains from acquisitions in the FoodTech segment are likely to have aided John Bean (JBT) in Q2.
Tenaris (TS) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Tenaris' (TS) Q2 performance is likely to have been hurt by lower prices and a reduction in U.S. drilling activity. A decline in raw material and energy costs is expected to have driven earnings.
What's in the Offing for Johnson Controls' (JCI) Q3 Earnings?
by Zacks Equity Research
Johnson Controls' (JCI) Q3 earnings are likely to have benefited from continued improvement in HVAC & Controls and cost-control initiatives.
What's in the Cards for Emerson (EMR) This Earnings Season?
by Zacks Equity Research
Underlying sales growth in the Americas region within the Intelligent Devices unit is likely to have aided Emerson's (EMR) Q3 performance.
Ingersoll Rand (IR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Ingersoll (IR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Luxfer (LXFR) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Luxfer (LXFR) delivered earnings and revenue surprises of -10% and 0.54%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Xylem (XYL) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Increasing costs and expenses, as well as forex woes, are likely to have hurt Xylem's (XYL) Q2 performance.
What's in Store for Zebra Technologies (ZBRA) in Q2 Earnings?
by Zacks Equity Research
Large customer order deferrals in the mobile computing business within the EVM segment are likely to hurt Zebra Technologies' (ZBRA) second-quarter 2023 performance.
What's in the Offing for Carlisle (CSL) in Q2 Earnings?
by Zacks Equity Research
Carlisle's (CSL) Q2 earnings are likely to have benefited from growing demand in the medical market and commercial aerospace business and favorable pricing policies.
A. O. Smith (AOS) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Robust demand for commercial and residential boilers and water treatment products is likely to have aided A. O. Smith's (AOS) Q2 performance.
Why Ingersoll (IR) Could Beat Earnings Estimates Again
by Zacks Equity Research
Ingersoll (IR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Allegion (ALLE) Set to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Allegion's (ALLE) Q2 earnings are likely to have benefited from strengthening demand in end markets and effective pricing, partly offset by the rising cost of sales.
What's in the Cards for IDEX (IEX) This Earnings Season?
by Zacks Equity Research
Softness across pharma, biopharma and nutrition end markets within the material processing technology business is likely to have hurt IDEX's (IEX) Q2 performance.